View all cases
UPC CFI 534/2025
Jun 16, 2025·EP3536712 · METHODS FOR REDUCING LIPOPROTEIN(A) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9)
- Case details
- StatusWritten PhaseActionGenericCategoryGeneric
- Parties
- Division
- Dusseldorf LD
- Technology
- ChemistryBiotechnology · Pharmaceuticals
- Language
- English
- EPO Opposition
- Amgen Inc.Withdrawn2024-02-29
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Dusseldorf LD | Locked |
| Judge Berenice Thom | Locked |
| Judge András Kupecz | Locked |
| Judge Ingo Rinken | Locked |
| Judge Xavier Dorland-Galliot | Locked |
At the UPC: Amgen Group (19 cases)·Sanofi Group (33 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 1 other proceedings
4 other defendants litigating the same or a related patent
UPC CoA 641/2025·UPC CoA 646/2025·UPC CFI 195/2025·CC 24999/2024
Start a free trial to see how each one ended.
More cases: Dusseldorf LD·2025
Documents
| Document title | Date | Public |
|---|---|---|
| Receipt | 2026-06-23 | Not public |
| Cover sheet | 2026-06-23 | Not public |
| Application document Defendant | 2026-06-23 | Not public |
| Receipt | 2026-03-17 | Not public |
| Cover sheet | 2026-03-17 | Not public |
| Document Defendant | 2026-03-17 | Not public |
| Receipt | 2026-03-16 | Not public |
| Cover sheet | 2026-03-16 | Not public |
| Application document Claimant | 2026-03-16 | Not public |
| Reply to application for cost decision | 2025-07-03 | Not public |
| Reply to application for cost decision | 2025-07-03 | Not public |
| Optional Order R. 156 | 2025-06-16 | Not public |
| Panel-Appointment | 2025-06-16 | Not public |
| Receipt | 2025-06-16 | Not public |
| Acknowledgement-of-lodging | 2025-06-13 | Not public |
| Application for cost decision | 2025-06-13 | Not public |